Local Institution

Wein

0 studies enrolling now · 2 studies all time

What they study most

Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia

Studies at this site

• Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib — Completed
• Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia — Completed